Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Colorado

CNS medication trials in Colorado

48 CNS medication studies are recruiting participants at sites in 11 cities across Colorado as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Colorado city with a recruiting study

By research area: Depression (14), Parkinson's Disease (12), Migraine (9), Multiple Sclerosis (6), Epilepsy (4), Schizophrenia (2), ADHD (1).

Aurora (22), Denver (11), Colorado Springs (7), Fort Collins (5), Centennial (4), Englewood (4), Grand Junction (2), Boulder (1), Edwards (1), Greeley (1), Westminster (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Colorado

Basic details from each study's public record (the 12 most recently updated of 48). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Denver
    Registry record
    NCT07226661 · updated
  2. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Recruiting in
    Aurora
    Registry record
    NCT07002034 · updated
  3. A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Definium Therapeutics US, Inc.
    Recruiting in
    Denver
    Registry record
    NCT07592689 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Colorado on ClinicalTrials.gov.

Schizophrenia: recently updated in Colorado

  1. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Recruiting in
    Denver
    Registry record
    NCT06887192 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Colorado on ClinicalTrials.gov.

Parkinson's disease: recently updated in Colorado

  1. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora · Colorado Springs · Greeley · and 1 more U.S. location
    Registry record
    NCT06623422 · updated
  2. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Denver · Grand Junction
    Registry record
    NCT06966700 · updated
  3. SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

    • Phase 1
    • Ages 40 to 80
    • All sexes
    Sponsor
    Serina Therapeutics
    Recruiting in
    Englewood
    Registry record
    NCT07422675 · updated
  4. An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Yale University
    Recruiting in
    Aurora
    Registry record
    NCT06996652 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Colorado on ClinicalTrials.gov.

Epilepsy: recently updated in Colorado

  1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Colorado Springs
    Registry record
    NCT07594119 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Colorado on ClinicalTrials.gov.

Migraine: recently updated in Colorado

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    Aurora
    Registry record
    NCT06972056 · updated
  2. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Recruiting in
    Denver
    Registry record
    NCT07616128 · updated
  3. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Aurora
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Colorado on ClinicalTrials.gov.

Ask about studies in Colorado

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call